 | LVP | Name: | ~{N}'-(2-fluorophenyl)-1,2-oxazole-5-carbohydrazide | Formula: | C10 H8 F N3 O2 | SMILES: | Fc1ccccc1NNC(=O)c2oncc2 | InChi: | InChI=1S/C10H8FN3O2/c11-7-3-1-2-4-8(7)13-14-10(15)9-5-6-12-16-9/h1-6,13H,(H,14,15) | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | ~{N}'-(2-fluorophenyl)-1,2-oxazole-5-carbohydrazide |
|
 | LWD | Name: | ~{N}-quinolin-6-ylbenzamide | Formula: | C16 H12 N2 O | SMILES: | O=C(Nc1ccc2ncccc2c1)c3ccccc3 | InChi: | InChI=1S/C16H12N2O/c19-16(12-5-2-1-3-6-12)18-14-8-9-15-13(11-14)7-4-10-17-15/h1-11H,(H,18,19) | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | ~{N}-quinolin-6-ylbenzamide |
|
 | LWV | Name: | 2-morpholin-4-ylaniline | Formula: | C10 H14 N2 O | SMILES: | Nc1ccccc1N2CCOCC2 | InChi: | InChI=1S/C10H14N2O/c11-9-3-1-2-4-10(9)12-5-7-13-8-6-12/h1-4H,5-8,11H2 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 2-morpholin-4-ylaniline |
|
 | LX4 | Name: | 4-cyclopentylcarbonylpiperazin-2-one | Formula: | C10 H16 N2 O2 | SMILES: | O=C1CN(CCN1)C(=O)C2CCCC2 | InChi: | InChI=1S/C10H16N2O2/c13-9-7-12(6-5-11-9)10(14)8-3-1-2-4-8/h8H,1-7H2,(H,11,13) | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 4-cyclopentylcarbonylpiperazin-2-one |
|
 | NE5 | Name: | 5-[(2~{R})-2-(4-nitrophenyl)-4-oxidanyl-5-oxidanylidene-3-(phenylcarbonyl)-2~{H}-pyrrol-1-yl]-2-oxidanyl-benzoic acid | Formula: | C24 H16 N2 O8 | SMILES: | OC(=O)c1cc(ccc1O)N2[CH](c3ccc(cc3)[N+](=O)=O)C(=C(O)C2=O)C(=O)c4ccccc4 | InChi: | InChI=1S/C24H16N2O8/c27-18-11-10-16(12-17(18)24(31)32)25-20(13-6-8-15(9-7-13)26(33)34)19(22(29)23(25)30)21(28)14-4-2-1-3-5-14/h1-12,20,27,29H,(H,31,32)/q+1/t20-/m1/s1 | Definition date: | 2019-11-26 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 5-[(2~{R})-2-(4-nitrophenyl)-4-oxidanyl-5-oxidanylidene-3-(phenylcarbonyl)-2~{H}-pyrrol-1-yl]-2-oxidanyl-benzoic acid |
|
 | LX7 | Name: | 1-[4-(trifluoromethyloxy)phenyl]thiourea | Formula: | C8 H7 F3 N2 O S | SMILES: | NC(=S)Nc1ccc(OC(F)(F)F)cc1 | InChi: | InChI=1S/C8H7F3N2OS/c9-8(10,11)14-6-3-1-5(2-4-6)13-7(12)15/h1-4H,(H3,12,13,15) | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 1-[4-(trifluoromethyloxy)phenyl]thiourea |
|
 | LXA | Name: | ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-2-methoxy-ethanamide | Formula: | C11 H13 N3 O2 | SMILES: | COCC(=O)NCc1[nH]c2ccccc2n1 | InChi: | InChI=1S/C11H13N3O2/c1-16-7-11(15)12-6-10-13-8-4-2-3-5-9(8)14-10/h2-5H,6-7H2,1H3,(H,12,15)(H,13,14) | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-2-methoxy-ethanamide |
|
 | LXJ | Name: | (3~{a}~{S},8~{a}~{S})-6-(phenylcarbonyl)-2,3,3~{a},7,8,8~{a}-hexahydropyrrolo[3,4-d]azepin-1-one | Formula: | C15 H16 N2 O2 | SMILES: | O=C1NC[CH]2C=CN(CC[CH]12)C(=O)c3ccccc3 | InChi: | InChI=1S/C15H16N2O2/c18-14-13-7-9-17(8-6-12(13)10-16-14)15(19)11-4-2-1-3-5-11/h1-6,8,12-13H,7,9-10H2,(H,16,18)/t12-,13+/m1/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | (3~{a}~{S},8~{a}~{S})-6-(phenylcarbonyl)-2,3,3~{a},7,8,8~{a}-hexahydropyrrolo[3,4-d]azepin-1-one |
|
 | LXM | Name: | [(3~{S},3~{a}~{S},8~{b}~{S})-3-(hydroxymethyl)-2,3,3~{a},8~{b}-tetrahydro-[1]benzofuro[3,2-b]pyrrol-1-yl]-phenyl-methanone | Formula: | C18 H17 N O3 | SMILES: | OC[CH]1CN([CH]2[CH]1Oc3ccccc23)C(=O)c4ccccc4 | InChi: | InChI=1S/C18H17NO3/c20-11-13-10-19(18(21)12-6-2-1-3-7-12)16-14-8-4-5-9-15(14)22-17(13)16/h1-9,13,16-17,20H,10-11H2/t13-,16-,17-/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | [(3~{S},3~{a}~{S},8~{b}~{S})-3-(hydroxymethyl)-2,3,3~{a},8~{b}-tetrahydro-[1]benzofuro[3,2-b]pyrrol-1-yl]-phenyl-methanone |
|
 | LXS | Name: | 3-ethyl-1-[(1~{R},8~{S},9~{S},10~{S})-10-oxidanyl-11-oxatricyclo[6.2.1.0^{2,7}]undeca-2(7),3,5-trien-9-yl]imidazolidine-2,4-dione | Formula: | C15 H16 N2 O4 | SMILES: | CCN1C(=O)CN([CH]2[CH](O)[CH]3O[CH]2c4ccccc34)C1=O | InChi: | InChI=1S/C15H16N2O4/c1-2-16-10(18)7-17(15(16)20)11-12(19)14-9-6-4-3-5-8(9)13(11)21-14/h3-6,11-14,19H,2,7H2,1H3/t11-,12-,13-,14+/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 3-ethyl-1-[(1~{R},8~{S},9~{S},10~{S})-10-oxidanyl-11-oxatricyclo[6.2.1.0^{2,7}]undeca-2(7),3,5-trien-9-yl]imidazolidine-2,4-dione |
|
 | LZV | Name: | ethyl (6~{R})-3-oxidanylidenespiro[1,2,5,6-tetrahydropyrazolo[1,2-a]pyrazole-7,1'-cyclopentane]-6-carboxylate | Formula: | C13 H20 N2 O3 | SMILES: | CCOC(=O)[CH]1CN2N(CCC2=O)C13CCCC3 | InChi: | InChI=1S/C13H20N2O3/c1-2-18-12(17)10-9-14-11(16)5-8-15(14)13(10)6-3-4-7-13/h10H,2-9H2,1H3/t10-/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | ethyl (6~{R})-3-oxidanylidenespiro[1,2,5,6-tetrahydropyrazolo[1,2-a]pyrazole-7,1'-cyclopentane]-6-carboxylate |
|
 | LZY | Name: | 8-fluoranyl-5-methyl-1,2,3,6-tetrahydro-1,5-benzodiazocin-4-one | Formula: | C11 H13 F N2 O | SMILES: | CN1Cc2cc(F)ccc2NCCC1=O | InChi: | InChI=1S/C11H13FN2O/c1-14-7-8-6-9(12)2-3-10(8)13-5-4-11(14)15/h2-3,6,13H,4-5,7H2,1H3 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 8-fluoranyl-5-methyl-1,2,3,6-tetrahydro-1,5-benzodiazocin-4-one |
|
 | M0D | Name: | 2-[(2R,5R,6S)-5-hydroxy-1,2,4,5,6,7-hexahydro-3H-2,6-methanoazocino[5,4-b]indol-3-yl]acetamide | Formula: | C16 H19 N3 O2 | SMILES: | N4(C1CC(c3c(C1)c2c(cccc2)n3)C(C4)O)CC(N)=O | InChi: | InChI=1S/C16H19N3O2/c17-15(21)8-19-7-14(20)12-6-9(19)5-11-10-3-1-2-4-13(10)18-16(11)12/h1-4,9,12,14,18,20H,5-8H2,(H2,17,21)/t9-,12+,14-/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 2-[(2R,5R,6S)-5-hydroxy-1,2,4,5,6,7-hexahydro-3H-2,6-methanoazocino[5,4-b]indol-3-yl]acetamide |
|
 | P8G | Name: | (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-methoxy-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]oxane-3,4,5-triol | Formula: | C25 H40 N6 O16 | SMILES: | CO[CH]1O[CH](CO)[CH](O)[CH](OCc2cn(nn2)[CH]3O[CH](CO)[CH](O)[CH](OCc4cn(nn4)[CH]5O[CH](CO)[CH](O)[CH](O)[CH]5O)[CH]3O)[CH]1O | InChi: | InChI=1S/C25H40N6O16/c1-42-25-20(41)22(16(37)13(6-34)47-25)44-8-10-3-31(29-27-10)24-19(40)21(15(36)12(5-33)46-24)43-7-9-2-30(28-26-9)23-18(39)17(38)14(35)11(4-32)45-23/h2-3,11-25,32-41H,4-8H2,1H3/t11-,12-,13-,14+,15+,16+,17+,18-,19-,20-,21+,22+,23-,24-,25-/m1/s1 | Definition date: | 2019-08-06 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[4-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-methoxy-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]-1,2,3-triazol-1-yl]oxane-3,4,5-triol |
|
 | P8J | Name: | methyl 3-O-[(1-beta-D-galactopyranosyl-1H-1,2,3-triazol-4-yl)methyl]-beta-D-galactopyranoside | Formula: | C16 H27 N3 O11 | SMILES: | c2c(COC1C(C(OC)OC(CO)C1O)O)nnn2C3C(C(C(C(CO)O3)O)O)O | InChi: | InChI=1S/C16H27N3O11/c1-27-16-13(26)14(10(23)8(4-21)30-16)28-5-6-2-19(18-17-6)15-12(25)11(24)9(22)7(3-20)29-15/h2,7-16,20-26H,3-5H2,1H3/t7-,8-,9+,10+,11+,12-,13-,14+,15-,16-/m1/s1 | Definition date: | 2019-08-06 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | methyl 3-O-[(1-beta-D-galactopyranosyl-1H-1,2,3-triazol-4-yl)methyl]-beta-D-galactopyranoside |
|
 | OSG | Name: | 7-[3-(aminomethyl)-4-propoxyphenyl]-4-methylquinolin-2-amine | Formula: | C20 H23 N3 O | SMILES: | c21nc(N)cc(c1ccc(c2)c3ccc(OCCC)c(c3)CN)C | InChi: | InChI=1S/C20H23N3O/c1-3-8-24-19-7-5-14(10-16(19)12-21)15-4-6-17-13(2)9-20(22)23-18(17)11-15/h4-7,9-11H,3,8,12,21H2,1-2H3,(H2,22,23) | Definition date: | 2019-07-03 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 7-[3-(aminomethyl)-4-propoxyphenyl]-4-methylquinolin-2-amine |
|
 | OSJ | Name: | 7-[3-(aminomethyl)-4-ethoxyphenyl]-4-methylquinolin-2-amine | Formula: | C19 H21 N3 O | SMILES: | NCc1cc(ccc1OCC)c2ccc3c(c2)nc(cc3C)N | InChi: | InChI=1S/C19H21N3O/c1-3-23-18-7-5-13(9-15(18)11-20)14-4-6-16-12(2)8-19(21)22-17(16)10-14/h4-10H,3,11,20H2,1-2H3,(H2,21,22) | Definition date: | 2019-07-03 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 7-[3-(aminomethyl)-4-ethoxyphenyl]-4-methylquinolin-2-amine |
|
 | OU4 | Name: | 7-{3-(aminomethyl)-4-[(1,3-oxazol-4-yl)methoxy]phenyl}-4-methylquinolin-2-amine | Formula: | C21 H20 N4 O2 | SMILES: | c1(N)nc2c(c(c1)C)ccc(c2)c4ccc(OCc3ncoc3)c(CN)c4 | InChi: | InChI=1S/C21H20N4O2/c1-13-6-21(23)25-19-8-15(2-4-18(13)19)14-3-5-20(16(7-14)9-22)27-11-17-10-26-12-24-17/h2-8,10,12H,9,11,22H2,1H3,(H2,23,25) | Definition date: | 2019-07-03 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 7-{3-(aminomethyl)-4-[(1,3-oxazol-4-yl)methoxy]phenyl}-4-methylquinolin-2-amine |
|
 | OU7 | Name: | 7-{3-(aminomethyl)-4-[(1,3-thiazol-5-yl)methoxy]phenyl}-4-methylquinolin-2-amine | Formula: | C21 H20 N4 O S | SMILES: | c21nc(N)cc(c1ccc(c2)c4ccc(OCc3cncs3)c(CN)c4)C | InChi: | InChI=1S/C21H20N4OS/c1-13-6-21(23)25-19-8-15(2-4-18(13)19)14-3-5-20(16(7-14)9-22)26-11-17-10-24-12-27-17/h2-8,10,12H,9,11,22H2,1H3,(H2,23,25) | Definition date: | 2019-07-03 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 7-{3-(aminomethyl)-4-[(1,3-thiazol-5-yl)methoxy]phenyl}-4-methylquinolin-2-amine |
|
 | OUJ | Name: | 7-{3-(aminomethyl)-4-[(1,3-thiazol-4-yl)methoxy]phenyl}-4-methylquinolin-2-amine | Formula: | C21 H20 N4 O S | SMILES: | c1c(cc(CN)c(c1)OCc2cscn2)c4ccc3c(cc(nc3c4)N)C | InChi: | InChI=1S/C21H20N4OS/c1-13-6-21(23)25-19-8-15(2-4-18(13)19)14-3-5-20(16(7-14)9-22)26-10-17-11-27-12-24-17/h2-8,11-12H,9-10,22H2,1H3,(H2,23,25) | Definition date: | 2019-07-05 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 7-{3-(aminomethyl)-4-[(1,3-thiazol-4-yl)methoxy]phenyl}-4-methylquinolin-2-amine |
|
 | P3E | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-[2-azanyl-7-[(3-methylphenyl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate | Formula: | C28 H36 N10 O18 P3 | SMILES: | Cc1cccc(Cn2c[n+]([CH]3O[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(=O)OC[CH]4O[CH]([CH](O)[CH]4O)n5cnc6C(=O)NC(=Nc56)N)[CH](O)[CH]3O)c7N=C(N)NC(=O)c27)c1 | InChi: | InChI=1S/C28H35N10O18P3/c1-11-3-2-4-12(5-11)6-36-10-38(22-16(36)24(44)35-28(30)33-22)26-20(42)18(40)14(54-26)8-52-58(47,48)56-59(49,50)55-57(45,46)51-7-13-17(39)19(41)25(53-13)37-9-31-15-21(37)32-27(29)34-23(15)43/h2-5,9-10,13-14,17-20,25-26,39-42H,6-8H2,1H3,(H8-,29,30,32,33,34,35,43,44,45,46,47,48,49,50)/p+1/t13-,14-,17-,18-,19-,20-,25-,26-/m1/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-[2-azanyl-7-[(3-methylphenyl)methyl]-6-oxidanylidene-1~{H}-purin-9-ium-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate |
|
 | MJ4 | Name: | (2R)-1-{[(5-methylthiophen-2-yl)methyl]amino}propan-2-ol | Formula: | C9 H15 N O S | SMILES: | N(CC(C)O)Cc1ccc(s1)C | InChi: | InChI=1S/C9H15NOS/c1-7(11)5-10-6-9-4-3-8(2)12-9/h3-4,7,10-11H,5-6H2,1-2H3/t7-/m1/s1 | Definition date: | 2019-04-04 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | (2R)-1-{[(5-methylthiophen-2-yl)methyl]amino}propan-2-ol |
|
 | E5L | Name: | 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide | Formula: | C23 H39 N O4 | SMILES: | CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC | InChi: | InChI=1S/C23H39NO4/c1-7-8-9-10-11-12-13-14-15-23(2,3)22(25)24-21-19(27-5)16-18(26-4)17-20(21)28-6/h16-17H,7-15H2,1-6H3,(H,24,25) | Definition date: | 2019-10-18 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 2,2-dimethyl-~{N}-(2,4,6-trimethoxyphenyl)dodecanamide |
|
 | EVU | Name: | 4-[2-[4-(aminomethyl)phenyl]phenyl]piperazin-2-one | Formula: | C17 H19 N3 O | SMILES: | NCc1ccc(cc1)c2ccccc2N3CCNC(=O)C3 | InChi: | InChI=1S/C17H19N3O/c18-11-13-5-7-14(8-6-13)15-3-1-2-4-16(15)20-10-9-19-17(21)12-20/h1-8H,9-12,18H2,(H,19,21) | Definition date: | 2020-02-06 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | 4-[2-[4-(aminomethyl)phenyl]phenyl]piperazin-2-one |
|
 | F8L | Name: | [(2Z,6E,10E,14Z,18E,22Z,26Z)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl] [(2S,3S,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl] hydrogen phosphate | Formula: | C55 H91 O8 P | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO[P](O)(=O)O[CH]1O[CH](CO)[CH](O)[CH]1O | InChi: | InChI=1S/C55H91O8P/c1-42(2)21-12-22-43(3)23-13-24-44(4)25-14-26-45(5)27-15-28-46(6)29-16-30-47(7)31-17-32-48(8)33-18-34-49(9)35-19-36-50(10)37-20-38-51(11)39-40-61-64(59,60)63-55-54(58)53(57)52(41-56)62-55/h21,23,25,27,29,31,33,35,37,39,52-58H,12-20,22,24,26,28,30,32,34,36,38,40-41H2,1-11H3,(H,59,60)/b43-23?,44-25?,45-27-,46-29-,47-31+,48-33-,49-35+,50-37+,51-39-/t52-,53-,54+,55+/m1/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-04-24 | Release date: | 2020-04-29 | Identifier: | [(2~{Z},6~{E},10~{E},14~{Z},18~{E},22~{Z},26~{Z})-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl] [(2~{S},3~{S},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl] hydrogen phosphate |
|